Search: WFRF:(Manell Hannes) >
Altered Plasma Leve...
-
Manell, HannesUppsala universitet,Institutionen för medicinsk cellbiologi
(author)
Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes
- Article/chapterEnglish2016
Publisher, publication year, extent ...
-
The Endocrine Society,2016
-
printrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:uu-292749
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-292749URI
-
https://doi.org/10.1210/jc.2015-3885DOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
CONTEXT: Proglucagon-derived hormones are important for glucose metabolism, but little is known about them in pediatric obesity and type 2 diabetes mellitus (T2DM).OBJECTIVE: Fasting and postprandial levels of proglucagon-derived peptides glucagon, GLP-1, and glicentin in adolescents with obesity across the glucose tolerance spectrum were investigated.DESIGN: This was a cross-sectional study with plasma hormone levels quantified at fasting and during an oral glucose tolerance test (OGTT).SETTING: This study took place in a pediatric obesity clinic at Uppsala University Hospital, Sweden.PATIENTS AND PARTICIPANTS: Adolescents with obesity, age 10-18 years, with normal glucose tolerance (NGT, n = 23), impaired glucose tolerance (IGT, n = 19), or T2DM (n = 4) and age-matched lean adolescents (n = 19) were included.MAIN OUTCOME MEASURES: Outcome measures were fasting and OGTT plasma levels of insulin, glucagon, active GLP-1, and glicentin.RESULTS: Adolescents with obesity and IGT had lower fasting GLP-1 and glicentin levels than those with NGT (0.25 vs 0.53 pM, P < .05; 18.2 vs 23.6 pM, P < .01) and adolescents with obesity and T2DM had higher fasting glucagon levels (18.1 vs 10.1 pM, P < .01) than those with NGT. During OGTT, glicentin/glucagon ratios were lower in adolescents with obesity and NGT than in lean adolescents (P < .01) and even lower in IGT (P < .05) and T2DM (P < .001).CONCLUSIONS: Obese adolescents with IGT have lowered fasting GLP-1 and glicentin levels. In T2DM, fasting glucagon levels are elevated, whereas GLP-1 and glicentin levels are maintained low. During OGTT, adolescents with obesity have more products of pancreatically than intestinally cleaved proglucagon (ie, more glucagon and less GLP-1) in the plasma. This shift becomes more pronounced when glucose tolerance deteriorates.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Staaf, JohanUppsala universitet,Pediatrik,Institutionen för medicinsk cellbiologi(Swepub:uu)johst547
(author)
-
Manukyan, LevonUppsala universitet,Institutionen för medicinsk cellbiologi(Swepub:uu)levma108
(author)
-
Kristinsson, HjaltiUppsala universitet,Institutionen för medicinsk cellbiologi(Swepub:uu)hjakr151
(author)
-
Cen, JingUppsala universitet,Institutionen för medicinsk cellbiologi(Swepub:uu)jince383
(author)
-
Stenlid, RasmusUppsala universitet,Institutionen för medicinsk cellbiologi
(author)
-
Ciba, IrisUppsala universitet,Institutionen för medicinsk cellbiologi,Pediatrik(Swepub:uu)irici655
(author)
-
Forslund, AndersUppsala universitet,Institutionen för medicinsk cellbiologi,Pediatrik(Swepub:uu)andeforsl
(author)
-
Bergsten, PeterUppsala universitet,Institutionen för medicinsk cellbiologi(Swepub:uu)peteberg
(author)
-
Uppsala universitetInstitutionen för medicinsk cellbiologi
(creator_code:org_t)
Related titles
-
In:Journal of Clinical Endocrinology and Metabolism: The Endocrine Society101:3, s. 1181-11890021-972X1945-7197
Internet link
Find in a library
To the university's database